会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明申请
    • LIGANDS FOR ANTIBODY AND FC-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMOTOGRAPHY IV
    • 抗生素和FC融合蛋白质纯化的配体通过染色体色谱IV
    • WO2013117707A1
    • 2013-08-15
    • PCT/EP2013/052564
    • 2013-02-08
    • GRAFFINITY PHARMACEUTICALS GMBHBITTERMANN, HolgerARNOLD, MarcNEUMANN, ThomasOTT, IngeSCHMIDT, KristinaSEKUL, Renate
    • BITTERMANN, HolgerARNOLD, MarcNEUMANN, ThomasOTT, IngeSCHMIDT, KristinaSEKUL, Renate
    • C07K1/22B01D15/38C07D317/66
    • C07K1/22B01D15/3804B01D15/3809B01J20/289B01J20/3204B01J20/3208B01J20/321B01J20/3212B01J20/3219B01J20/3274C07D231/56C07D403/12C07D405/14C07D413/12C07D417/04C07D417/12C07D417/14C07D513/04C07K16/065C07K16/1027C07K16/22C07K16/2863C07K16/2866
    • The present invention relates to the use, for affinity purification of an antibody or an fragment of an antibody, of a ligand-substituted matrix comprising a support material and at least one ligand covalently bonded to the support material, the ligand being represented by formula (I) L-(Sp) v -Ar 1 -Am-Ar 2 wherein L is the linking point on the support material to which the ligand is attached; Sp is a spacer group; v is 0 or 1; Am is an amide group -NR 1 -C(O)-, and wherein either NR 1 is attached to Ar 1 and -C(O)- is attached to Ar 2 , or -C(O)- is attached to Ar 1 and NR 1 is attached to Ar 2 ; and R 1 is hydrogen or C 1 to C 4 alkyl, more preferably hydrogen or methyl; and most preferably hydrogen; Ar 1 is a 5-, 6- or 7-membered mononuclear aromatic ring or partially saturated aromatic ring connected to Sp or L via a chemical bond and which is optionally furthermore (a) attached to a further 5- or 6-membered mononuclear aromatic ring via a chemical bond; or (b) fused to a mononuclear or binuclear aromatic ring as part of a multinuclear ring system wherein Ar 1 is directly connected to Am via a chemical bond present on the said 5-, 6- or 7- membered aromatic ring constituting Ar 1 , or indirectly via a chemical bond which is either present at the further 5- or 6-membered aromatic ring attached to Ar 1 , or on the further 5- or 6- membered aromatic ring fused to Ar 1 ; and wherein Ar 1 is either not further substituted or attached to at least one substituent selected from C 1 to C 4 alkyl; C 3 and C 4 cycloalkyl; C 2 to C 4 alkenyl;; C 2 to C 4 alkynyl; a halogen; C 1 to C 4 haloalkyl;;; hydroxyl-substituted C 1 to C 4 alkyl; C 1 to C 4 alkoxy; hydroxyl-substituted C 1 to C 4 alkoxy; halogen-substituted C 1 to C 4 alkoxy; C 1 to C 4 alkylamino; C 1 to C 4 alkylthio; -NO 2 ; =O; =S; =NH; -OH?; and combinations thereof; Ar 2 is a 5- or 6-membered mononuclear aromatic ring which is unsubstituted, or via a chemical bond attached to at least one substituent selected from C 1 to C 6 alkyl; C 3 to C 6 cycloalkyl; C 2 to C 6 alkenyl; C 5 and C 6 cycloalkenyl; C 2 to C 6 alkynyl; a halogen; C 1 to C 6 haloalkyl; hydroxyl-substituted C 1 to C 6 alkyl; C 1 to C 6 alkoxy; hydroxyl-substituted C 1 to C 6 alkoxy; halogen-substituted C 1 to C 6 alkoxy; C 1 to C 6 alkylamino; C 1 to C 6 alkylthio; carbamoyl; methylenedioxy; ethylenedioxy; -OH; SH; a 5- or 6-membered mononuclear aromatic ring; and combinations thereof; and wherein Ar 2 optionally, further to the substituents to which it may be attached via a chemical bond as cited above, is fused to a 5- or 6-membered mononuclear aromatic ring as part of a multinuclear ring system.
    • 本发明涉及用于亲和纯化抗体或抗体片段的配体取代基质,其包括载体材料和至少一种与载体材料共价结合的配体,所述配体由式( I)L-(Sp)v -Ar1-Am-Ar2其中L是与配体连接的载体材料上的连接点; Sp是间隔基; v为0或1; Am是酰胺基-NR1-C(O) - ,并且其中NR1与Ar1连接,-C(O) - 连接到Ar2上,或-C(O) - 连接到Ar1上,并且NR1连接到 AR2; 并且R 1是氢或C 1至C 4烷基,更优选氢或甲基; 最优选氢; Ar1是通过化学键连接到Sp或L的5-,6-或7-元单核芳环或部分饱和芳环,并且任选地另外(a)连接到另外的5或6元单核芳环上 通过化学键; 或(b)与作为多核环体系的一部分的单核或双核芳环稠合,其中Ar1通过存在于构成Ar1的所述5-,6-或7-元芳族环上的化学键或间接直接与Am直接连接 通过化学键,其存在于与Ar 1连接的另外的5或6元芳香环上,或存在于与Ar 1稠合的另外的5或6元芳环上; 并且其中Ar1不被进一步取代或连接至至少一个选自C 1至C 4烷基的取代基; C3和C4环烷基; C2至C4烯基; C2至C4炔基; 卤素 C1至C4卤代烷基; 羟基取代的C1至C4烷基; C1至C4烷氧基; 羟基取代的C1至C4烷氧基; 卤素取代的C1至C4烷氧基; C1至C4烷基氨基; C1〜C4烷硫基; NO 2; = O; = S; = NH; -哦?; 及其组合; Ar2是未取代的或通过连接至至少一个选自C 1至C 6烷基的取代基的化学键的5或6元单环芳环; C3至C6环烷基; C2至C6烯基; C5和C6环烯基; C2〜C6炔基; 卤素 C1至C6卤代烷基; 羟基取代的C1至C6烷基; C1至C6烷氧基; 羟基取代的C1至C6烷氧基; 卤素取代的C1至C6烷氧基; C1至C6烷基氨基; C1至C6烷硫基; 氨基甲酰基; 亚甲二氧基; 亚; -哦; SH; 5-或6-元单核芳环; 及其组合; 并且其中Ar2任选地进一步与其所连接的取代基通过如上所述的化学键连接,作为多核环体系的一部分与5或6元单核芳香环稠合。